Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Atea Pharmaceuticals, Inc.

Pharmaceutical Preparations · Boston, MA, United States

  1. PrincipalsJanet MJ HammondChief Development OfficerJean-Pierre SommadossiPresident, CEO, and ChairmanJohn VavrickaChief Commercial Officerand 3 more
  2. CompanyAtea Pharmaceuticals, Inc.Boston, MA, United States
  3. Phone line+1 (857) 284-8891General business
Request a quote

Atea Pharmaceuticals, Inc. is an SEC-registered Nasdaq-listed company (ticker AVIR) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 6

Chief executive

Jean-Pierre SommadossiPresident, CEO, and Chairman

Finance

Wayne FosterEVP, Chief Accounting Officer

Sales & commercial

John VavrickaChief Commercial Officer
Everyone else on file (3)
Janet MJ HammondChief Development Officer
Maria Arantxa HorgaChief Medical Officer
Andrea CorcoranOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Janet MJ Hammond — Chief Development Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Jean-Pierre Sommadossi — President, CEO, and Chairman

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. John Vavricka — Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Maria Arantxa Horga — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers